Biological E, Takeda join hands to accelerate access to Dengue Vaccine in endemic areas Ruchika Sharma29 Feb 2024 3:00 PM ISTHyderabad: Takeda and Biological E. Limited (BE), an India-based Vaccines and Pharmaceutical Company, has announced a strategic partnership...
Japan's Takeda Pharma profit slips 13 percent, pipeline bolsters outlook Ruchika Sharma5 Feb 2023 10:00 AM ISTThe company said core operating profit, which strips out non-recurring items, increased 26 percent in the nine-month period.
European Commission approves Qdenga as second dengue virus vaccine Dr. Kamal Kant Kohli20 Dec 2022 7:45 AM ISTGlobally incidence of infection of dengue virus has increased 8-fold in the past 20 years and has become endemic in most tropical European Overseas...
Takeda Dengue Tetravalent Vaccine QDENGA gets European Commission nod Ruchika Sharma10 Dec 2022 10:00 AM ISTQDENGA (TAK-003) is a dengue vaccine that is based on a live-attenuated dengue serotype 2 virus, which provides the genetic “backbone” for all four...
